Seasonal prevalence of MS disease activity

Neurology

Volumn 75, Issue 9, 2010, Pages 799-806

  Meier, D S ^a   Balashov, K E ^b   Healy, B ^a   Weiner, H L ^a   Guttmann, C R G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRECIPITATION; PREVALENCE; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; SEASONAL VARIATION; SOLAR RADIATION; STEROID THERAPY; SUMMER; TEMPERATURE; ADULT; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; PATHOLOGY; RISK FACTOR; SEASON; TRENDS;

ADULT; COHORT STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEASONS;

EID: 77956387587     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181f0734c     Document Type: Article

References (23)

1. Sibley WA, Bamford CR, Clark K. Clinical viral infections and multiple sclerosis. Lancet 1985;1:1313-1315.
2. Bamford CR, Sibley WA, Thies C. Seasonal variation of multiple sclerosis exacerbations in Arizona. Neurology 1983;33:697-701.
3. Ogawa G, Mochizuki H, Kanzaki M, Kaida K, Motoyoshi K, Kamakura K. Seasonal variation of multiple sclerosis exacerbations in Japan. Neurol Sci 2004;24:417-419.
4. Wüthrich R, Rieder HP. The seasonal incidence of multiple sclerosis in Switzerland. Eur Neurol 1970;3:257-264.
5. Jin YP, de Pedro-Cuesta J, Soderstrom M, Link H. Incidence of optic neuritis in Stockholm, Sweden, 1990-1995: II: time and space patterns. Arch Neurol 1999;56: 975-980.
6. Balashov KE, Olek MJ, Smith DR, Khoury SJ, Weiner HL. Seasonal variation of interferon-gamma production in progressive multiple sclerosis. Ann Neurol 1998;44:824-828.
7. Killestein J, Rep MH, Meilof JF, et al. Seasonal variation in immune measurements and MRI markers of disease activity in MS. Neurology 2002;58:1077-1080.
8. Stewart N, Taylor B, Ponsonby AL, et al. The effect of season on cytokine expression in multiple sclerosis and healthy subjects. J Neuroimmunol 2007;188:181-186.
9. Auer DP, Schumann EM, Kumpfel T, Gossl C, Trenk-walder C. Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 2000;47:276-277.
10. Killestein J, Rep MH, Barkhof F, et al. Active MRI lesion appearance in MS patients is preceded by fluctuations in circulating T-helper 1 and 2 cells. J Neuroimmunol 2001; 118:286-294.
11. Rovaris M, Comi G, Sormani MP, Wolinsky JS, Ladkani D, Filippi M. Effects of seasons on magnetic resonance imaging-measured disease activity in patients with multiple sclerosis. Ann Neurol 2001;49:415-416.
12. Tremlett H. Effects of seasons on magnetic resonance imaging-measured disease activity in patients with multiple sclerosis. Ann Neurol 2001;50:422-423.
13. Weiner HL, Guttmann CR, Khoury SJ, et al. Serial magnetic resonance imaging in multiple sclerosis: correlation with attacks, disability, and disease stage. J Neuroimmunol 2000;104:164-173.
14. Meier DS, Weiner HL, Guttmann CR. MR imaging intensity modeling of damage and repair in multiple sclerosis: relationship of short-term lesion recovery to progression and disability. AJNR Am J Neuroradiol 2007; 28:1956-1963.
15. Meier DS, Guttmann CR. Time-series modeling of MS lesion development. Neuroimage 2006;32:531-537.
16. Barkhof F, Polman CH, Radue EW, et al. Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results. Arch Neurol 2007;64:1292-1298.
17. Sormani MP, Bruzzi P, Miller DH, Gasperini C, Barkhof F, Filippi M. Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials. J Neurol Sci 1999;163:74-80.
18. Cook RJ, Wei W. Selection effects in randomized trials with count data. Stat Med 2002;21:515-531.
19. Meier DS, Weiner HL, Guttmann CR. Time-series modeling of multiple sclerosis disease activity: a promising window on disease progression and repair potential? Neurotherapeutics 2007;4:485-498.
20. Sibley WA, Foley JM. Infection and Immunization in Multiple Sclerosis. Ann NY Acad Sci 1965;122:457-466.
21. Chitnis T, Glanz B, Jaffin S, Healy B. Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Mult Scler 2009;15:627-631.
22. Rao AB, Richert N, Howard T, et al. Methylpred-nisolone effect on brain volume and enhancing lesions in MS before and during IFN-beta-1b. Neurology 2002;59:688-694.
23. Cotton F, Weiner HL, Jolesz FA, Guttmann CR. MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals. Neurology 2003;60:640-646.